97 results about "Bacteroides" patented technology

The invention discloses an intestinal bacterial composition for improving a cognitive function and relieving neuroinflammation and an application of the intestinal bacterial composition, and belongs to the technical field of biomedicine and microbiology, the intestinal bacterial composition is composed of a Lachnospiraceae bacterium, a Bacteroides multiforme and a Roseburiatestinae bacterium, and the intestinal bacterial composition is prepared from the following raw materials of the following raw materials of the intestinal bacterial composition: the Lachnospiraceae bacterium, the Bacteroides multiforme and the Roseburiatestinae bacterium, the Roseburiatestinae bacterium, the Roseburiatestinae bacterium, the Roseburiatestinae bacterium, the Roseburiatestinae bacterium, the Roseburiatestinae bacterium and the like. Experimental research results show that a modular synergistic effect exists among the helicobacter hirsuticus, the bacteroides multiforme and the Roche enterobacter, and the pharmaceutical composition has a remarkable neuroprotective effect on a cognitive impairment mouse model and an Alzheimer disease mouse model, can improve the cognitive function and relieve neuroinflammation, and can be used for preparing a neuroprotective agent for treating the cognitive impairment mouse model and the Alzheimer disease mouse model. A new thought and method can be provided for treatment of cognitive impairment related diseases and neuroinflammation related diseases.

The present invention provides an application of a thorn sugar neutral polysaccharide in preparing a drug for preventing and / or treating ulcerative colitis, and belongs to the field of medical technology. Animal experimental results show that after the thorn sugar neutral polysaccharide is used in a mouse model of ulcerative colitis, the phenomenon of colon shortening can be alleviated, the production of harmful bacteria can be inhibited, the abundance of Helicobacter genus can be reduced, the number of beneficial bacteria can be increased, and the abundance of Lactobacillus genus, Bacteroides genus and Oscillatory Spirochete genus can be increased. Therefore, the thorn sugar neutral polysaccharide of the present invention can be used as a drug for preparing a drug for preventing or treating ulcerative colitis.

The invention discloses stropharia rugoso-annulata polysaccharide as well as a preparation method and application thereof. The monosaccharide of the stropharia rugoso-annulata polysaccharide disclosed by the invention comprises glucose, galactose, mannose and galacturonic acid; the weight-average molecular weight of the stropharia rugoso-annulata polysaccharide is 1.4712 * 10 < 4 > to 1.623 * 10 < 4 > Da; the main chain of the stropharia rugoso-annulata polysaccharide contains-> 6)-alpha-D-(O-Me)-Galp-(1->, 1, 6-Glc, 1, 3-Man and 1.3-Gal exist in the main chain or a side chain, and terminal residues contain T-Glc and T-Gal. According to the invention, by constructing a DSS induced UC mouse model, the influence of Stropharia rugosoannulata polysaccharide (SRP1) on UC mice is investigated. Results show that the stropharia rugoso-annulata polysaccharide has a certain treatment effect on ulcerative colitis. In-vivo experiments show that the stropharia rugoso-annulata polysaccharide disclosed by the invention can increase abundance of bacteroides and thick-wall funguses and reduce abundance of proteobacteria and deferribacterium funguses; in-vitro experiments show that the stropharia rugoso-annulata polysaccharide can increase the abundance of beneficial bacteria bacteroides, reduce the abundance of harmful bacteria Escherichia-Shigella and Enterococcus, and increase the content of short-chain fatty acids.

The invention discloses a bifidobacterium animalis subsp. Lactis BA-C53 and an application of the bifidobacterium animalis subsp. Lactis BA-C53 in products for improving bone health. The bifidobacterium animalis subsp. Lactis BA-C53 is classified and named as bifidobacterium animalis subsp. Lactis Bifidobacterium animalis subsp. Lactis BA-C53, the preservation number is CCTCC NO: M 2024460, the preservation unit is China Center for Type Culture Collection, and the preservation time is March 11, 2024. The bifidobacterium animalis subsp. Lactis BA-C53 can effectively improve the steady state of intestinal flora of a mouse with osteoporosis induced by estrogen deficiency, so that the relative abundance of phylum firmicalis and phylum actinomycetes is increased, the relative abundance of phylum bacteroides is reduced, and then short-chain fatty acid is generated to activate intestinal immunity and maintain the integrity of an intestinal barrier, so that the osteoporosis caused by estrogen deficiency is inhibited. Meanwhile, osteoclast differentiation can be inhibited by regulating NFATC1, RANKL and OPG pathways, then osteoporosis is relieved, and the compound can be widely applied to preparation of food and drugs.

The invention relates to a biomarker for screening intestinal flora transplantation donors and application of the biomarker. The biomarker comprises intestinal flora and metabolites thereof, the intestinal flora comprises phylum firmicalis, bacteroides and the like, and the metabolites comprise short-chain fatty acid, tryptophan, indole, 5-hydroxytryptamine, lipopolysaccharide and the like. According to the method, the intestinal flora of different crowds is deeply analyzed, the relationship between each related index of the intestinal flora and the intestinal flora transplantation effect is studied, sufficient clinical verification is carried out, a biomarker for screening the intestinal flora transplantation donor is excavated, and a standard for judging whether the intestinal flora transplantation donor is qualified or not is established; and a new method and a new idea are provided for efficiently and accurately screening intestinal flora transplantation donors.

The embodiment of the invention discloses application of lactobacillus delbrueckii. The application is characterized in that the lactobacillus delbrueckii is applied to inhibition of mesophilic aerobic bacteria, saccharomycetes, mould and coliform bacteria. The lactobacillus delbrueckii has a preservation number of CGMCC No.11247. In the lactobacillus delbrueckii activating process, bacteriocin can be generated and can remarkably inhibit the mesophilic aerobic bacteria, saccharomycetes, mould and coliform bacteria on the surfaces of fruits and vegetables, so that the preservation effect of thefruits and vegetables can be improved. Furthermore, secondary metabolites of the lactobacillus delbrueckii can be biodegraded and digested by human bodies, and are healthy and harmless to human bodies.

The invention relates to the field of oral cavities, in particular to a biomarker for drug-related jawbone necrosis and application of the biomarker. The invention provides application of a biomarker to preparation of a drug-related jawbone necrosis detection product. The biomarker comprises an oral metabolite and an oral flora, the oral metabolite comprises one or a combination of more of spermine, 7-methylguanine, hypoxanthine, quinoline and taurine. And the oral flora comprises bacteria of bacteroides, peptostreptococcaceae, porphyrinomonas, butyric acid vibrio, micromonas and moniliaceae, and the oral flora comprises bacteria of bacteroides, peptostreptococcaceae, porphyrinomonas, butyric acid vibrio. According to the application, metabolite and microorganisms which are characteristic-changed in an MRONJ microenvironment are discovered, the pathogenesis that the metabolite and the microorganisms possibly participate in the MRONJ is predicted, the risk that an individual suffers from the MRONJ is expected to be judged in an early stage through oral metabolite and microorganism marker screening, occurrence of the MRONJ is prevented by adjusting a medication strategy or modifying oral flora in time, and the MRONJ is prevented from being damaged by the oral metabolite and the microorganism. Therefore, the method is of great significance to formulating a new osteoporosis clinical prevention and treatment strategy.

This invention belongs to the field of intestinal microbiome technology, specifically relating to a capsular polysaccharide derived from Bacteroides salorlis CSP6, its preparation method, and its applications. The monosaccharide composition of the capsular polysaccharide is mainly composed of fucose, glucose, and glucosamine, with a molecular weight of 7.139 × 10⁻⁶. 5 The strain described is deposited at the China Center for Type Culture Collection (CCTCC), accession number CCTCC NO: M20221993. In vitro studies have found that the capsular polysaccharide derived from Bacteroides Salieris CSP6 can inhibit α-glucosidase; in vivo animal experiments have demonstrated that this capsular polysaccharide can inhibit the rise in postprandial blood glucose and has a hypoglycemic effect.

The invention provides a preparation method of an apple water kefir beverage and application of the apple water kefir beverage in lowering cholesterol. The method comprises the following steps: preparing apple juice, activating water kefir grains, inoculating the activated water kefir grains into the apple juice, and fermenting to prepare the apple water kefir beverage. The volatile component change in the fermentation process is analyzed through GC-MS and GC-IMS systems, it is proved that the unique bouquet characteristic and flavor coordination of the apple water kefir beverage are improved through water kefir grain fermentation, and meanwhile the organic acid composition is optimized. A mouse model verifies that the apple water kefir beverage has the effect of reducing cholesterol, can reduce liver lipid droplets, total cholesterol, low-density lipoprotein and triglyceride levels, and also can regulate intestinal microbial communities (increase firmicobacteria, bacteroides and faecalis bacteria). The apple water kefir beverage disclosed by the invention has wide market potential and provides a scientific basis for the development of functional beverages.

The invention discloses application of acid-producing bacteroides in treatment of hepatic fibrosis and hepatocellular carcinoma. In-vitro cell experiments verify that the Bacteroides acidogenes and the culture medium thereof can inhibit LX2 cell fibrosis induced by TGF-beta, can inhibit the activity of LX2, Huh7 and 97H cells and can inhibit the cell proliferation capacity at the same time, and further, in a hepatocellular carcinoma spontaneous animal model induced by diethylnitrosamine and carbon tetrachloride, the application of the Bacteroides acidogenes and the culture medium of the Bacteroides acidogenes and the culture medium of the Bacteroides acidogenes and the culture medium of the Bacteroides acidogenes in the hepatocellular carcinoma spontaneous animal model has the advantages of being capable of inhibiting the fibrosis of the LX2 cells induced by the TGF-beta and inhibiting the proliferation capacity of the cells. The inhibition effect of the acid-producing bacteroides on hepatic fibrosis and liver cancer progression is verified; the acid-producing bacteroides is recognized as probiotics and has low side effect risk, so that the acid-producing bacteroides has a good clinical application prospect.

The invention relates to the technical field of water treatment, in particular to a preparation method and application of a phycomycete compound. The phycomycete compound is applied to nitrogen and phosphorus removal and surface water treatment. Wherein the chlorella vulgaris and the quadruplex obliquus have strong reproductive capacity and strong adaptive capacity to environment, and absorb various elements such as carbon, nitrogen and phosphorus from water through autotrophy, heterotrophy and polyculture growth; activated sludge containing bacteroides and pseudomonas can degrade complex organic compounds, has metabolic capabilities such as heterotrophic denitrification and the like, and is beneficial to forming a co-culture system with microalgae in the initial culture stage; and nitrifying and denitrifying bacteria are compounded to consolidate the nitrogen removal environment order, so that the water body is effectively purified and the water color is good. The phycomycete compound obtained by the invention not only can be suitable for high-nitrogen simulation wastewater of a laboratory, but also can be applied to in-situ treatment of an actual river channel, has remarkable environmental benefits and has a wide application prospect.

The invention relates to the technical field of biomedicine, and discloses application of bacteroides sailli as a biomarker in preparation of sepsis diagnosis and / or prognosis evaluation products. The kit for the auxiliary diagnosis of the sepsis comprises a reagent for detecting the bacteroides sailli (Bacteroides sailli), and the reagent is used for detecting the bacteroides sailli (Bacteroides sailli). As a detection variable of sepsis, the single bacterium of Bacteroides sailli has high specificity and sensitivity, can be applied to diagnosis of sepsis patients as a detection marker, is high in accuracy, provides an intestinal flora detection means for the sepsis patients, provides a bacterium source basis for judging sepsis and intestinal flora disorder of the patients according to the intestinal flora detection means, and has a good application prospect. And a basis is provided for later-stage intestinal bacteria transplantation.

The invention belongs to the technical field of organic substrates, and particularly relates to an organic substrate preparation process based on complex microbial inoculant synergistic fermentation, which comprises the following steps: selecting agricultural wastes, livestock and poultry manure and food industry byproducts, and carrying out staged fermentation by adopting complex microorganisms such as bacillus, streptomyces, clostridium and bacteroides; the decomposition efficiency of degradation-resistant substances such as cellulose and lignin is obviously improved. By combining precise temperature control and oxygen concentration adjustment strategies, the stability of the fermentation process is enhanced, nitrogen volatilization is reduced, and the total nitrogen content is stabilized at 1.2-1.5%. Nitrogen-fixing bacteria and phosphate solubilizing bacteria are introduced in the after-ripening stage, the biological activity of the matrix is improved, the screening process ensures that the finished product is uniform in particle size and few in impurities, the content of organic matter reaches 45% or above, the pH value is stabilized at 6.5-7.5, excellent agricultural performance is achieved, and efficient resource utilization of organic waste is achieved; the problems that in the prior art, organic matter degradation is not thorough, the controllability of the fermentation process is poor, nutrient loss is serious, and the quality of a finished product is unstable are effectively solved.

The present invention discloses a selenium-rich probiotic that affects irinotecan-induced diarrhea and intestinal flora in mice, establishes an irinotecan-induced diarrhea mouse model, and administers selenium-rich probiotics by long-term oral gavage to evaluate its effects on irinotecan-induced diarrhea and intestinal flora in mice. The mice in the experimental group were given selenium-rich probiotics by oral gavage every day, and the weight, diarrhea grade, immune index, intestinal flora and ileum tissue structure of the mice were measured. The results show that selenium-rich probiotics can inhibit weight loss and reduced immune function caused by irinotecan; reduce the incidence of diarrhea and the average diarrhea grade in mice, and alleviate irinotecan-induced diarrhea in mice; reduce the content of Clostridium, Escherichia coli and Bacteroidetes associated with β-D-glucuronidase, and increase the content of bifidobacteria in the intestine; alleviate the damage of intestinal mucosa, cells and glands of mice caused by irinotecan.

The main purpose of the present invention is to provide a Monascus pilosus and a composition for reducing weight and improving intestinal flora, the composition comprising the Monascus pilosus and / or a monascus fermentation product thereof, or a functional component comprising the monascus fermentation product. The invention also aims to provide application of the monascus in preparation of the composition for reducing weight and improving intestinal flora. The composition disclosed by the invention has the capabilities of reducing body weight and improving intestinal flora, such as reducing the ratio of the phylum firmicutes to the phylum Bacteroides.

The invention provides an application of beta-1, 3-glucan in preparation of a product for regulating intestinal flora balance. The invention finds that the beta-1, 3-glucan can inhibit the growth of intestinal harmful bacteria such as desulfatovibrio, Coriobacteria UCG-002, Colidextribacter and the like, and can promote and / or not inhibit the growth of intestinal probiotics such as clostridium sensricitum 1, Bacteroides, Lactobacillus, Clostridium praeparatum and the like, which indicates that the beta-1, 3-glucan is suitable for preparing a product for regulating the balance of intestinal flora, and also shows that the beta-1, 3-glucan is suitable for preparing a product for regulating the balance of intestinal flora.

The invention discloses a Lactobacillus paracasei-composite prebiotic compound preparation, a preparation method and application thereof, and belongs to the technical field of microbial preparations. The compound preparation is prepared from the lactobacillus paracasei PC-92 and compound prebiotics in an optimized compatibility mode, the compound prebiotics are composed of trehalose, inulin and fructo-oligosaccharide, and the adding amount of the compound prebiotics is as follows: 1.959% of the trehalose, 1.029% of the inulin and 1.582% of the fructo-oligosaccharide. According to the casei paracasei-composite prebiotic compound preparation, the preparation method and the application thereof, the compound preparation can remarkably improve intestinal flora disorder of mice with the ulcerative colitis induced by DSS, adjust abundance of key flora such as lactobacillus and bacteroides, reduce disease activity indexes, maintain intestinal microecological balance and improve the intestinal immunity of the mice. The method can be applied to the field of functional food, health care products or medicines, and provides a new scheme for intestinal health intervention.

The application discloses a method for identifying direct discharge of domestic sewage and application thereof. The method comprises the following steps: detecting the copy number concentration of bacteriophage marker genes and Bacteroides marker genes of adjacent two days of a water body to be detected respectively, calculating the ratio of the copy number concentration of the bacteriophage marker genes and the copy number concentration of the Bacteroides marker genes per day, and calculating the ratio between the two days of the water body to be detected, and combining a specific ratio threshold to determine whether the direct discharge of domestic sewage appears in the water body to be detected, and the day when the direct discharge of domestic sewage appears can be accurately determined, so that the direct discharge of domestic sewage can be traced and controlled; wherein the bacteriophage marker gene is CPQ_064, and the Bacteroides marker gene is BacHum, BacH, HuBac and / or HF183.

The invention discloses an anti-cryptosporidium synbiotics preparation as well as a preparation method and application thereof. The invention provides a complex microbial inoculant. The complex microbial inoculant comprises bifidobacterium pseudolongum and bacteroides multiforme. In the complex microbial inoculant, the quantity ratio of the bifidobacterium pseudolongum to the bacteroides multiforme is (1-10): (1-10). The invention also provides a composition which comprises the complex microbial inoculant and guar gum. The invention further discloses application of the complex microbial inoculant or the composition in preparation of products for treating and / or preventing cryptosporidiosis and application of the complex microbial inoculant or the composition in preparation of products for improving intestinal functions. The invention has industrial value in the field of medicine.

A probiotic formulation is provided including one or more bacteria, bacterial strains or bacterial species of the genus Veillonella, genus Faecalibacterium, genus Phascolarctobacteria, genus Oscillospira, genus Ruminococcus, genus Bacteroides, genus Blautia, family Christensenellaceae, genus Dialister, or phylum cyanobacteria.

The invention discloses a kit for detecting intestinal core bacteria by a TaqMan real-time fluorescent quantitative PCR (Polymerase Chain Reaction) method, and belongs to the technical field of kits. The kit disclosed by the invention comprises standard positive templates of nine common intestinal core bacteria and nine groups of specific primers and probes which are required in a PCR amplification process and correspond to the standard positive templates. The kit disclosed by the invention is simple, convenient and rapid to operate; the specificity is good and the sensitivity is high; complicated raw information data analysis does not need to be carried out; the intestinal core bacteria can be detected and quantified without high-throughput sequencing, and three bacteria can be detected in one reaction hole, so that the cost is greatly reduced. The kit provided by the invention can be used for rapidly and quantitatively detecting nine intestinal core bacteria including bifidobacterium, lactobacillus, prevotella, bacteroides and the like, can partially replace a high-throughput detection method which is higher in cost and more complicated to operate according to research and diagnosis purposes, and is suitable for being widely popularized in clinical detection and laboratory research.

The invention discloses application of nano copper oxide, a degradation agent and a method for reducing quinclorac in soil and increasing crop yield. The degradation agent comprises nano copper oxide, bacteroides and menococcus virens. The method comprises the following steps: (1) adding bacteroides and pseudomonas virens into acidic wet soil polluted by quinclorac; (2) adding nano copper oxide into the soil; and (3) planting crops. According to the invention, the nano copper oxide is added into the soil, and cooperates with the synergistic use of bacteroides and chloromeniscus, so that efficient and sustainable degradation of quinclorac is realized, the crop yield is increased, and the dual benefits of pesticide degradation and crop yield increase are realized.

Engineered Bacteroides thetaiotaomicron (Bt) strains, including deletion mutant strains, and methods of use thereof are provided. Methods of delivering a therapeutic compound to a gut microbiome of a subject include generating an engineered Bacteroides thetaiotaomicron (Bt) strain to overproduce outer membrane vesicles (OMVs); loading a target therapeutic compound into the OMVs; and colonizing the gut microbiome of the subject with the engineered Bt strain. In some embodiments, the subject has at least one of lactose intolerance, phenylketonuria, inflammatory bowel disease, and a chronic intestinal condition.

The invention belongs to the technical field of intestinal microorganisms, and particularly relates to bacteroides polydeformation ZF-8 and application thereof in preparation of drugs and food for treating and / or preventing inflammatory bowel diseases. The invention relates to a bacterial strain, in particular to a bacterial strain ZF-8, and the bacterial strain ZF-8 is a bacterial strain ZF-8. The strain is separated from the intestinal tract of a healthy human body and is preserved in the China Center for Type Culture Collection (CCTCC), and the preservation number is CCTCC NO: M 2025618. The bacterial strain can protect colorectal mucosa from being damaged and repair the damaged intestinal mucosa, so that symptoms such as loose stool, hematochezia and colorectal shortening are improved, weight loss caused by intestinal injury and inflammation is relieved, and finally, the inflammatory bowel disease is treated.

The present invention discloses dendrobium officinale glycolipid, its preparation method and antioxidant application. The dendrobium officinale glycolipid is a diglyceride rich in glucose, mannose, linoleic acid and 9,12,15-octadecatrienoic acid. The invention also discloses the alcohol extraction process of dendrobium officinale glycolipid, its applications in increasing the abundance of intestinal acid-producing bacteroides, up-regulating the expression of piceatannol and down-regulating the expression of 1-naphthol, and enhancing the activities of superoxide dismutase and glutathione peroxidase in the body, so as to ultimately improve the antioxidant capacity in vivo.

This invention, entitled "A Composition Containing Pentadecanoic Acid, Parabacterium Species Outer Membrane Vesicles Containing the Composition, and Their Applications," belongs to the field of probiotics and microbial preparations technology. The technical problem this invention aims to solve is that beneficial live bacteria have weak colonization ability in the gut, are easily affected by the gastrointestinal environment, exhibit unstable individual responses, and struggle to simultaneously address immune regulation and barrier repair. This invention provides a composition containing pentadecanoic acid, Parabacterium Species-derived outer membrane vesicles, and their applications. The outer membrane vesicles are derived from *Parabacterium difficile* and are rich in pentadecanoic acid, palmitic acid, and octadecanoic acid. The composition and outer membrane vesicles prepared by this invention can significantly inhibit macrophage M1 polarization and reduce pro-inflammatory cytokines. TNF-α , IL-6 and IL-1 β It can lower the expression level of [something], reduce intracellular reactive oxygen species levels, improve mitochondrial function, significantly alleviate symptoms of colitis induced by sodium dextran sulfate, regulate the intestinal flora structure, and increase the abundance of beneficial bacteria.

The invention discloses a microecological preparation capable of regulating and controlling abundance of intestinal bifidobacteria in a targeted mode and application of the microecological preparation, the microecological preparation is composed of intestinal symbiotic bacteria and prebiotics, the intestinal symbiotic bacteria are bacteroides, and the prebiotics are polysaccharide containing N-acetylglucosamine. The prebiotics and the bacteroides multiforme CCFM1441 are combined for use, the prebiotics N-acetylglucosamine can be effectively released, nutrition is provided for bifidobacterium longum, and proliferation of the bifidobacterium longum is promoted. Further, in vitro and in vivo experiments prove that there is a strong cross-feeding activity between Bacteroides multiforme CCFM1441 and Bifidobacterium longum based on prebiotics. The beneficial microecological preparation can promote proliferation of bifidobacterium longum in intestinal tracts in a targeted manner, improves intestinal flora imbalance caused by antibiotics, and further has a huge application prospect in preparation of products (such as food, drugs or health care products) for improving intestinal health.

This invention belongs to the field of intestinal microbiome technology, and particularly relates to the application of a capsular polysaccharide derived from Bacteroides Salilsii CSP6 in the treatment and / or prevention of inflammatory bowel disease. The Bacteroides Salilsii strain is... Bacteroides salyersiae CSP6. This strain was isolated from the intestine of healthy humans and deposited at the China Center for Type Culture Collection (CCTCC), accession number CCTCC NO: M 20221993. In vivo experiments showed that the capsular polysaccharide derived from Bacteroides Salieris CSP6 can protect the colorectal mucosa from damage and promote the repair of damaged intestinal mucosa, thereby improving symptoms such as loose stools, rectal bleeding, and shortened colon and rectum, reducing weight loss caused by intestinal damage and inflammation, and ultimately exerting a therapeutic effect on inflammatory bowel disease.

The invention discloses an application of premna microphylla pectin in preparation of a product for preventing and improving diet-induced obesity. The premna pubescens pectin is prepared from premna pubescens leaves as a raw material through extraction, purification and other processes. According to the present invention, the research on the high fat diet induced obese mouse model finds that the body lipid metabolism is regulated by remodeling the intestinal flora structure, particularly reducing the ratio of the phylum firmicutes to the phylum bacteroides, and specifically enriching the beneficial flora such as Muribacaceae and the like by using the premna microphylla pectin; experimental results prove that the premna microphylla pectin can significantly inhibit pathological hypertrophy of adipocytes, reduce visceral fat accumulation, effectively control weight gain and improve dyslipidemia and liver fatty degeneration, and has good biological safety.

To find out a useful living body-regulating function in a treated product of Abelmoschus manihot and to provide a functional use thereof.SOLUTION: An intestinal environment-improving agent comprising a processed product of Abutilon striata as an active ingredient, wherein the intestinal environment-improving agent increases bacteria of the genus Lactobacillusmurinus and / or the genus Parabacteroides.SELECTED DRAWING: Figure 5